Gerresheimer
Gerresheimer AG, headquartered in Düsseldorf, Germany, is a leading global partner for the pharmaceutical and healthcare industries. Founded in 1864, the company has established a strong presence in Europe, North America, and Asia, specialising in the production of high-quality glass and plastic packaging solutions. With a focus on innovation, Gerresheimer offers a diverse range of products, including vials, syringes, and inhalers, designed to meet the stringent requirements of the healthcare sector. Their commitment to quality and sustainability sets them apart in a competitive market. Recognised for their advanced manufacturing capabilities and expertise, Gerresheimer has achieved significant milestones, positioning themselves as a trusted supplier to major pharmaceutical companies worldwide. Their dedication to excellence continues to drive their success in the industry.
DitchCarbon Score
How does Gerresheimer's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Glass Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Gerresheimer's score of 38 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Gerresheimer's reported carbon emissions
In 2024, Gerresheimer AG reported total carbon emissions of approximately 1,256,418,000 kg CO2e, comprising 256,418,000 kg CO2e from Scope 1, 152,600,000 kg CO2e from Scope 2, and a significant 1,302,738,000 kg CO2e from Scope 3 emissions. This marks a slight decrease in Scope 1 emissions from 2023, which were about 262,029,000 kg CO2e, while Scope 2 emissions also saw a reduction from 193,153,000 kg CO2e in the previous year. Gerresheimer has set ambitious targets to reduce its carbon footprint, aiming for a 50% reduction in Scope 1 and Scope 2 emissions by 2030, using 2019 as the baseline year. This commitment is further reinforced by their Science Based Targets initiative (SBTi) targets, which include a 52% reduction in absolute Scope 1 and Scope 2 emissions by FY2030, and a 64% reduction in Scope 3 emissions per EUR value added by FY2034. The company is actively working towards these goals, with progress reported as being on track for both the two-year and five-year milestones. Gerresheimer's commitment to sustainability reflects its dedication to reducing its environmental impact within the healthcare equipment and supplies sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 258,527,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 304,016,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 401,084,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Gerresheimer is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
